Healthcare · NYSE · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .
AMERICAN SHARED HOSPITAL SERVICES (AMS) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores AMS at 44.7/100 on a 32-signal composite quality model, placing it at rank #1,904 of 2,961 stocks — the bottom half of the AI-ranked universe. AMS scores in the top quartile across earnings quality (89.7). Areas of concern include revenue scale (5.2) and institutional flow (6.0), which score below median versus the broader universe. Shareholder dilution risk is elevated at 47.5/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), AMERICAN SHARED HOSPITAL SERVICES reports quarterly revenue of $8.4M, net income of $-514.0K, an operating margin of -10.8%. Top institutional holders of AMS by reported 13-F value include DIMENSIONAL FUND ADVISORS, LPL Financial, RENAISSANCE TECHNOLOGIES, based on the most recent SEC filings. AMS trades on the NYSE exchange and files with the SEC under CIK 744825. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate AMS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for AMERICAN SHARED HOSPITAL SERVICES directly from SEC EDGAR.
AI Quality Score
44.7/100
AI Rank
#1,904
Revenue
$8.4M
Net Income
$-514.0K
Free Cash Flow
$2.2M
Operating Margin
-10.8%
| Period | Form | Revenue | Net income | Operating margin |
|---|---|---|---|---|
| FY 2025 | 10-K | $28.1M | $-1.6M | -12.8% |
| FY 2024 | 10-K | $28.3M | $2.2M | -9.9% |
| FY 2023 | 10-K | $21.3M | $610.0K | 1.3% |
| FY 2022 | 10-K | $19.7M | $1.3M | 12.3% |
| FY 2021 | 10-K | $17.6M | $194.0K | 7.7% |
| FY 2020 | 10-K | $17.8M | $-7.1M | -53.0% |
| Institution | Shares | Value | Reported |
|---|---|---|---|
| DIMENSIONAL FUND ADVISORS | 102,140 | $161.4K | 2026-06-30 |
| LPL Financial | 81,386 | $128.6K | 2026-06-30 |
| RENAISSANCE TECHNOLOGIES | 57,695 | $91.2K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT | 55,662 | $87.9K | 2026-06-30 |
| NewEdge Advisors | 29,725 | $47.0K | 2026-06-30 |
| JAMES INVESTMENT RESEARCH | 29,725 | $47.0K | 2026-06-30 |
| BRIDGEWAY CAPITAL MANAGEMENT | 29,124 | $46.0K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT | 26,497 | $41.9K | 2026-06-30 |
| VANGUARD FIDUCIARY | 25,363 | $40.1K | 2026-06-30 |
| XTX Topco Ltd | 19,107 | $30.2K | 2026-06-30 |
13F Pro Quality Score
Rank #1,904 of 2,961 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
AI-extracted from the 10-Q filed 2026-08-13 — Q2 2026 (quarter ended June 30, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.
Lower Gamma Knife procedures offset by higher PBRT revenues; PBRT revenues increased $425K driven by higher volumes and reimbursement.
AI-extracted and verified against SEC EDGAR filing text. Not investment advice.